Back to search

Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients

Data up to Jan 2025

Published1998
Citations58
References34

Total Citations Per Year

Abstract

References (34)

A RATING SCALE FOR DEPRESSION

1960 • 30,921 citations

A New Depression Scale Designed to be Sensitive to Change

1979 • 12,729 citations

Time-related predictors of suicide in major affective disorder

1990 • 1,037 citations

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

1986 • 382 citations

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia

1994 • 301 citations

Anxious depressions

1984 • 284 citations

The Relationship of Anxiety and Depression: A Review of the Literature

1986 • 265 citations

Treatment of major depression

1993 • 255 citations

Follow-up and family study of anxious depression

1991 • 241 citations

Neurotic illness and its response to anxiolytic and antidepressant treatment

1980 • 216 citations

Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.

1995 • 174 citations

A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression

1994 • 162 citations

A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients

1996 • 156 citations

Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.

1994 • 134 citations

Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.

1994 • 130 citations

Efficacy and Tolerability of Once-Daily Venlafaxine Extended Release (XR) in Outpatients With Major Depression

1997 • 109 citations

Optimal dose regimen for paroxetine.

1992 • 107 citations

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia

1996 • 106 citations

Sertraline 50 mg daily: the optimal dose in the treatment of depression

1995 • 91 citations

Efficacy of venlafaxine in depressive illness in general practice

1997 • 79 citations

Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.

1994 • 77 citations

Long-Term Safety and Clinical Acceptability of

1994 • 68 citations

Effect of dose escalation after low-dose fluoxetine therapy.

1989 • 64 citations

Once-Daily Venlafaxine Extended Release (XR) and Venlafaxine Immediate Release (IR) in Outpatients with Major Depression

1997 • 61 citations

Targeting treatment in patients with mixed symptoms of anxiety and depression.

1990 • 59 citations

Is Baseline Agitation a Relative Contraindication for a Selective Serotonin Reuptake Inhibitor

1994 • 49 citations

Appropriateness of drugs prescribed by primary care physicians for depressed outpatients

1979 • 47 citations

The effect of paroxetine on anxiety and agitation associated with depression.

1992 • 39 citations

Depression with anxiety and atypical depression.

1993 • 29 citations

Venlafaxine in depressed geriatric outpatients: an open-label clinical study.

1995 • 28 citations

SSRIs in anxious-agitated depression

1995 • 23 citations

Efficacy of venlafaxine treatment in depressed patients with psychomotor retardation or agitation: A metaanalysis

1995 • 11 citations

The anxiety factor in depression

1995 • 8 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...